Calapoğlu M - Search Results

1

A study on 4-acylamino-4,5-dihydro-1H-1,2,4-triazol-5-ones.

Alkan M, Yüksek H, Islamoğlu F, Bahçeci S, Calapoğlu M, Elmastaş M, Akşit H, Ozdemir M. Alkan M, et al. Among authors: calapoglu m. Molecules. 2007 Aug 13;12(8):1805-16. doi: 10.3390/12081805. Molecules. 2007. PMID: 17960089 Free PMC article.

2

Synthesis, acidity and antioxidant properties of some novel 3,4-disubstituted-4,5-dihydro-1H-1,2,4-triazol-5-one derivatives.

Alkan M, Yüksek H, Gürsoy-Kol O, Calapoğlu M. Alkan M, et al. Among authors: calapoglu m. Molecules. 2008 Jan 19;13(1):107-21. doi: 10.3390/molecules13010107. Molecules. 2008. PMID: 18259134 Free PMC article.

3

Preparation, GIAO NMR calculations and acidic properties of some novel 4,5-dihydro-1H-1,2,4-triazol-5-one derivatives with their antioxidant activities.

Yüksek H, Alkan M, Cakmak I, Ocak Z, Bahçeci Ş, Calapoğlu M, Elmastaş M, Kolomuç A, Aksu H. Yüksek H, et al. Among authors: calapoglu m. Int J Mol Sci. 2008 Jan;9(1):12-32. doi: 10.3390/ijms9010012. Epub 2008 Jan 8. Int J Mol Sci. 2008. PMID: 19325716 Free PMC article.

4

Connexin 32 mutation in a Turkish family with X-linked Charcot-Marie-Tooth disease.

Sahin N, Tan M, Kalay E, Calapoglu M, Karaguzel A. Sahin N, et al. Among authors: calapoglu m. Int J Neurosci. 2003 Jun;113(6):777-85. doi: 10.1080/00207450390200972. Int J Neurosci. 2003. PMID: 12775342

5

Evaluation of the atherogenic tendency of lipids and lipoprotein content and their relationships with oxidant-antioxidant system in patients with psoriasis.

Vanizor Kural B, Orem A, Cimşit G, Yandi YE, Calapoglu M. Vanizor Kural B, et al. Among authors: calapoglu m. Clin Chim Acta. 2003 Feb;328(1-2):71-82. doi: 10.1016/s0009-8981(02)00373-x. Clin Chim Acta. 2003. PMID: 12559600

6

Decreased neutrophil antioxidative enzyme activities and increased lipid peroxidation in hyperlipoproteinemic human subjects.

Efe H, Değer O, Kirci D, Karahan SC, Orem A, Calapoğlu M. Efe H, et al. Among authors: calapoglu m. Clin Chim Acta. 1999 Jan;279(1-2):155-65. doi: 10.1016/s0009-8981(98)00178-8. Clin Chim Acta. 1999. PMID: 10064127

7

Novel human pathological mutations. Gene symbol: GDAP1. Disease: Charcot-Marie-Tooth disease 4A.

Sahin-Calapoglu N, Soyoz M, Tan M, Calapoglu M, Ozcelik N. Sahin-Calapoglu N, et al. Among authors: calapoglu m. Hum Genet. 2009 Apr;125(3):342. Hum Genet. 2009. PMID: 19320013 No abstract available.

8

Novel GDAP1 mutation in a Turkish family with CMT2K (CMT2K with novel GDAP1 mutation).

Sahin-Calapoglu N, Tan M, Soyoz M, Calapoglu M, Ozcelik N. Sahin-Calapoglu N, et al. Among authors: calapoglu m. Neuromolecular Med. 2009;11(2):106-13. doi: 10.1007/s12017-009-8062-5. Epub 2009 Apr 19. Neuromolecular Med. 2009. PMID: 19381883

9

Genetic study of demyelinating form of autosomal-recessive Charcot-Marie-tooth diseases in a Turkish family.

Sahin-Calapoglu N, Soyoz M, Calapoglu M, Ozcelik N. Sahin-Calapoglu N, et al. Among authors: calapoglu m. Int J Neurosci. 2009;119(8):1179-89. doi: 10.1080/00207450902869906. Int J Neurosci. 2009. PMID: 19922348

10

Increased plasma fibronectin levels in patients with acute myocardial infarction complicated with left ventricular thrombus.

Orem C, Celik S, Orem A, Calapoğlu M, Erdöl C. Orem C, et al. Among authors: calapoglu m. Thromb Res. 2002 Jan 1;105(1):37-41. doi: 10.1016/s0049-3848(01)00414-5. Thromb Res. 2002. PMID: 11864705

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

27 results

Search Page

Filters